Trials / Completed
CompletedNCT00573742
Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients
Non-interventional Study on Uncontrolled Hypertensive Patients for Evaluating Efficacy of Candesartan Cilexetil as Monotherapy or add-on Therapy.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,940 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to observe treatment with candesartan cilexetil 16mg for 8 weeks, in uncontrolled hypertensive patients, in improvement of achieving of treatment goals and impact on blood pressure level in patients with uncontrolled hypertension treated with candesartan cilexetil.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Candesartan Cilexeotil 16mg |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2007-12-14
- Last updated
- 2010-08-19
Locations
16 sites across 1 country: Romania
Source: ClinicalTrials.gov record NCT00573742. Inclusion in this directory is not an endorsement.